Pseudoprogression With Checkpoint Inhibitors in Non-Small Cell Lung Cancer
2 Views
administrator
07/14/23
Apparent tumor growth followed by sustained regression, also known as pseudoprogression, is common following treatment with checkpoint inhibitors. In this discussion, panelists explore the implications of this phenomenon for patients with lung cancer.
To view more from the discussion, visit http://www.onclive.com/peer-ex....change/nsclc-outcome
-
Category
Show more
Facebook Comments
No comments found